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Protocols and strategies to study the migration of 
 veterinary drug residues into milk and dairy  products 
in licensed trials
C. Power, R. Sayers, B. O’Brien, A. Furey, M. Danaher and K. Jordan
During the review of Clare Power’s 
PhD thesis by Dr Jack Kay (Veterinary 
Medicines Directorate, Department for 
Environment, Food & Rural Affairs, 
UK [retired]), inaccuracies in the sec-
tion ‘What are Veterinary Drugs?’ were 
noted. As a result, the corresponding 
author wishes to replace the entire sec-
tion with the below section (ending before 
the section ‘MRLs and Public Health’) on 
p 186:
What are veterinary drugs?
Veterinary drugs are pharmacologically 
active substances used in the prevention, 
diagnosis and treatment of disease, dis-
order and injury in animals (Stolker et 
al. 2005). The use of veterinary drugs in 
the European Union (EU) is regulated 
by European Council regulation (EC No. 
470/2009, EU No. 37/2010). Regulation 
EC No. 470/2009 describes the procedure 
for the establishment of maximum residue 
limits (MRLs). The MRL is the maximum 
concentration of residue accepted by the 
EU in a food product obtained from an 
animal that has received a veterinary med-
icine or that has been exposed to a bio-
cidal product for use in animal husbandry. 
The EU requires by law that foodstuffs, 
such as meat, milk or eggs, obtained from 
animals treated with veterinary medicines 
or exposed to biocidal products used in 
animal husbandry must not contain any 
residue that might represent a hazard to 
the health of the consumer. Regulation 
EC No. 470/2009 describes the proce-
dure for the establishment of MRLs. Only 
pharmacologically active substances which 
have been classified according to article 14 
of 470/2009 as having a MRL, provisional 
MRLs or do not need a MRL may be 
administered to food producing animals. 
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In addition, Council Directive 96/23/EC 
specifically regulates control and monitor-
ing of pharmacologically active compounds 
(Stolker 2005). Residues of such compounds 
are divided into Group A compounds, i.e. 
prohibited substances in conformity with 
Table 2 of Regulation EU No. 37/2010 and 
Group B compounds, i.e. all registered 
veterinary medicines in conformity with 
Table 1 of Regulation EU No. 37/2010.
